Fred Hutch graduate student Adam Nguyen has won a F31 training award from the NIH to study a complex molecule called Tie2 ...

The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic ...

Accuray Incorporated ARAY recently revealed findings from an international multicenter analysis, showing that the CyberKnife ...

Accuray (ARAY) announced international retrospective multicenter analysis found that radiosurgery, or SRS, and fractionated ...

A live webcast will be available in the Investors section of the company's website at , and archived for 30 days following the presentation.

Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor ...

The FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK -positive locally advanced or metastatic ...

DelveInsight's Germ Cell Tumors Market Insights report includes a comprehensive understanding of current treatment practices, ...

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...

Ensartinib has received FDA approval for the first-line treatment of anaplastic lymphoma kinase (ALK)-positive locally ...

Microgravity is known to alter the muscles, bones, the immune system and cogni­tion, but little is known about its specific impact on the brain.

The FastGlioma tool could enable rapid and accurate detection of microscopic tumour infiltration, improving the success of ...